PROVIDER PROFILE · NPI 1144213091

Sharon Clay Matemavi

MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
930
Beneficiaries
—
Total drug cost
$76K
Distinct drugs
30
Brand share
18.1%
Top prescribed drugs
QUALITY · MIPS · 2024
No data available for this provider in 2024.
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

Hospital